Acknowledgements
Educational grants from AstraZeneca, Novartis, Pfizer and Roche were used to support both the Controversies in Breast Cancer 2008 meeting and publication of these ensuing short articles. This support is gratefully acknowledged.
This article has been published as part of Breast Cancer Research Volume 10 Supplement 4, 2008: Controversies in Breast Cancer 2008. The full contents of the supplement are available online at http://breast-cancer-research.com/supplements/10/S4.